RATE PALM: scReening for Atrial fibrillaTion of undiagnosEd Patients in chronic heArt faiLure outpatient clinic through Mydiagnostick

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON23782

Enrollment

500

Registered

2014-02-05

Start date

2014-03-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic heart failure Undiagnosed atrial fibrillation

Interventions

Mydiagnostick (MDS) is an easy to use, hand-held, heart rate monitoring device. It is not considered as an interventional tool by the CCMO. It is a CE approved instrument, used to screen for Atrial Fi

Eligibility

Inclusion criteria

Inclusion criteria: >18 years Chronic Heart Failure

Exclusion criteria

Exclusion criteria: Already diagnosed atrial fibrillation

Design outcomes

Primary

Measure	Time frame
The primary outcome is the number of newly diagnosed AF patients confirmed by ECG	—

Secondary

Measure	Time frame
Percentage of false positives: The number of (positive readings MDS-confirmed readings by ECG)/ all positive readings	—

Contacts

Public ContactM. Voorhaar

Boehringer Ingelheim BV P.O. box 8037

maarten.voorhaar@boehringer-ingelheim.com+31-(0)72-566 2457

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)